Reboot Pain (tDCS) for Chronic Pain
This study is investigating if a non-drug brain stimulation treatment called Transcranial Direct Current Stimulation (tDCS) can help reduce chronic pain. tDCS uses a low electrical current to stimulate specific parts of the brain. The study is for adults aged 18-89 who are experiencing chronic pain and are already receiving mental health treatment through the Accelerated Behavioral Health Program (ABHP) at the Emory Healthcare Veterans Program (EHVP). To join, your pain intensity must be 4 or more for most of the day at least 3 days a week, and you must have a primary care provider or pain management provider. We are looking for 100 participants. The main goal is to see if tDCS improves your pain, enjoyment of life, and general activity, as measured by the PEG scale, by the end of the treatment period.
- Study design
- This is an interventional study planning to enroll 100 participants. It will test the effects of tDCS on chronic pain.
- What's involved
- You will receive daily tDCS treatment sessions, lasting about 20 minutes each, for two weeks. You will also complete daily pain surveys, questionnaires, and standard clinical interviews.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain, enjoyment of life, and general activity will be measured at the start of the study and again 12 days after the treatment ends.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Reboot Pain (tDCS)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sheila Rauch, PhD · PRINCIPAL_INVESTIGATOR · Emory University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in PEG (Pain, Enjoyment of Life and General Activity) scaleBaseline, day 12 post-intervention (end of treatment)
The PEG scale includes 3 questions each rated from 0 (no pain) to 10 (Pain as bad as you can imagine) over the past 24 hours. Items include average pain, interference in enjoyment, and interference in general activity. Higher score correlates with worse study outcome.